Jump to main content
Jump to site search

Issue 20, 2018
Previous Article Next Article

Ultra-low voltage triggered release of an anti-cancer drug from polypyrrole nanoparticles

Author affiliations

Abstract

We have synthesized polypyrrole nanoparticles using three different oxidizing agents (hydrogen peroxide, chloroauric acid and ferric chloride) and shown that films assembled from these nanoparticles have significantly different drug release profiles. When ferric chloride is used as the oxidizing agent, it is possible to release drugs at voltages as low as −0.05 V, almost an order of magnitude lower than typically used voltages. These ultra-low voltage responsive nanoparticles widen the window of operation of conducting polymers and enable delivery of redox active drugs. As an example, we have shown pulsed release of the chemotherapeutic methotrexate at voltages as low as −0.075 V, demonstrating the potential application of these nanoparticles in cancer treatment. We have also verified the anti-tumor efficacy of the released drug using PC12 cell cultures.

Graphical abstract: Ultra-low voltage triggered release of an anti-cancer drug from polypyrrole nanoparticles

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Feb 2018, accepted on 06 May 2018 and first published on 07 May 2018


Article type: Paper
DOI: 10.1039/C8NR01259H
Citation: Nanoscale, 2018,10, 9773-9779
  •   Request permissions

    Ultra-low voltage triggered release of an anti-cancer drug from polypyrrole nanoparticles

    D. Samanta, N. Hosseini-Nassab, A. D. McCarty and R. N. Zare, Nanoscale, 2018, 10, 9773
    DOI: 10.1039/C8NR01259H

Search articles by author

Spotlight

Advertisements